Nestle India Faces FSSAI Action Over Claims On Infant Nutrition Products NAN Excella And Lactogen

The Food Safety and Standards Authority of India (FSSAI) has initiated three separate adjudication cases against Nestle India over alleged regulatory non-compliance involving infant nutrition products. The cases concern NAN Excella Pro Stage 1 and Lactogen Pro 1, with FSSAI flagging promotional claims related to “5 HMOs” and whey protein. The regulator also raised an issue with a follow-up formula after laboratory analysis found its biotin content below prescribed standards. A referral laboratory reportedly also found the sample non-conforming. FSSAI said the cases relate to alleged violations of regulations governing infant foods and promotional claims. No final penalty has been announced.